Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01597336 · ClinicalTrials.gov registry record · NA
Treatment of Abdominal Abscesses With or Without Fibrinolysis
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT01597336 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 92 participants.
The verdict
NCT01597336, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.
Interventions
- PROCEDURE Tissue plasminogen activator abscess flush
- PROCEDURE Saline flush of abscess
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01597336
The ClinicalTrials.gov registry entry for NCT01597336 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tissue plasminogen activator abscess flush is the first listed.
NCT01597336 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01597336 about?
NCT01597336 is a clinical study titled "Treatment of Abdominal Abscesses With or Without Fibrinolysis". The objective of this study is to evaluate the utility of fibrinolysis when draining an abdominal abscess as defined by length of stay after drainage.
What is the current status of trial NCT01597336?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2009-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01597336?
The interventions under investigation include: Tissue plasminogen activator abscess flush (PROCEDURE), Saline flush of abscess (PROCEDURE).
Who is sponsoring clinical trial NCT01597336?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.